Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.190
-0.020 (-1.65%)
At close: Feb 19, 2026, 4:00 PM EST
1.188
-0.002 (-0.19%)
After-hours: Feb 19, 2026, 6:45 PM EST
Heron Therapeutics Employees
Heron Therapeutics had 122 employees as of December 31, 2024. The number of employees decreased by 4 or -3.17% compared to the previous year.
Employees
122
Change (1Y)
-4
Growth (1Y)
-3.17%
Revenue / Employee
$1,271,287
Profits / Employee
-$111,295
Market Cap
218.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 122 | -4 | -3.17% |
| Dec 31, 2023 | 126 | -77 | -37.93% |
| Dec 31, 2022 | 203 | -99 | -32.78% |
| Dec 31, 2021 | 302 | 79 | 35.43% |
| Dec 31, 2020 | 223 | -8 | -3.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Arcturus Therapeutics Holdings | 176 |
| Alector | 156 |
| Silence Therapeutics | 116 |
| MediWound | 111 |
| Orchestra BioMed Holdings | 70 |
| Camp4 Therapeutics | 55 |
| Surrozen | 41 |
HRTX News
- 1 day ago - Heron: Near The Bottom Of A Trading Range Despite Positives - Seeking Alpha
- 2 days ago - Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - GlobeNewsWire
- 5 weeks ago - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth - GlobeNewsWire
- 2 months ago - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV) - GlobeNewsWire
- 3 months ago - Heron Therapeutics, Inc. (HRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress - GlobeNewsWire
- 4 months ago - Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors - GlobeNewsWire
- 4 months ago - Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewsWire